Nokia has proclaimed a private 5G trial at a production plant at the Institute of Immunobiological Technology (Bio-Manguinhos) in Rio de Janeiro in Brazil as a connectivity springboard to enhance vaccine manufacturing. Bio-Manguinhos produces active pharmaceutical ingredients (APIs; not those ones) for vaccines for...
